secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERUS CORP (CERS)
CIK:        0001020214
Form:       8-K
Filed at:   2024-07-02T23:59:59+00:00
Accession:  0000950170-24-080426
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cerus appoints Dean Gregory to Board of Directors
-------------------------------------------------

- Dean Gregory appointed to Cerus Board, effective July 1, 2024; term expires at 2027 annual meeting.
- Gregory is former President, Global Commercial Operations at Fresenius Kabi, with 30+ years in transfusion medicine.
- He receives initial RSU of 60,000 shares (3-year vest) and annual cash retainer of $45,000 under director policy.
- Gregory's industry expertise expected to support INTERCEPT Blood System expansion and manufacturing capacity growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1020214/000095017024080426/0000950170-24-080426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1020214/000095017024080426/cers-20240701.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-080426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer